Clinical Trial Update: Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes

View source ↗

Summary

An observational study evaluated the effectiveness and safety of liraglutide in adults with Type 2 Diabetes Mellitus. The sponsor listed is Novo Nordisk A/S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED